525 related articles for article (PubMed ID: 27265531)
1. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
3. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
4. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
5. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
6. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
Hacievliyagil SS; Mutlu LC; Temel İ
Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
[TBL] [Abstract][Full Text] [Related]
7. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation.
Daldegan MB; Teixeira MM; Talvani A
Braz J Med Biol Res; 2005 Sep; 38(9):1359-65. PubMed ID: 16138219
[TBL] [Abstract][Full Text] [Related]
8. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
10. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
11. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
12. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
13. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
14. [Markers of airway remodeling in induced sputum from healthy smokers].
Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P
Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
16. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
17. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
Higashimoto Y; Yamagata Y; Taya S; Iwata T; Okada M; Ishiguchi T; Sato H; Itoh H
Respirology; 2008 Jan; 13(1):128-33. PubMed ID: 18197923
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
